News In Brief
This article was originally published in The Silver Sheet
Executive Summary
Eight new offices established within ORA; FDA moves ahead with post-market surveillance initiatives.
You may also be interested in...
News In Brief
ISO 13485 will be baseline for IMDRF single-audit work plan; U.S. Marshals seize ultrasound gel made by Pharmaceutical Innovations ISO 13485 will be baseline for IMDRF single-audit work plan.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.